MB Therapeutics celebrates its firts anniversary!
A year ago, MB Therapeutics began its journey with a clear mission: to provide innovative solutions in the field of healthcare.
Blog
MB Therapeutics expands its leadership team
Who better than Damien Stefanelli as COO to lead the MB project and optimize our GMP-certified pharmaceutical operations?
GERPAC 2024 is coming soon!
Our team will be at GERPAC 2024 to showcase our innovations in 3D printing for personalized medicine. Come meet us!
Good Manufacturing Practices in the pharmaceutical industry
Discover the essentials of Good Manufacturing Practices (GMP) for the pharmaceutical industry. Ensure compliance with regulatory quality and safety standards.
The benefits of 3D printed medicines
What if you had the choice of your medication?
Discover the benefits of pharmaceutical 3D printing of medications for patients.
Sébastien Gallice : “It’s a great curiosity that arises about new concepts”
Find the interview of Sébastien Gallice, president of PREF and pharmacist in one of the largest preparatory pharmacies in France.
Pharmaceutical 3D printing of medications in response to waste
Explore how 3D printing offers innovative solutions to reduce waste. Discover the various approaches for a sustainable future.
How can pharmaceutical 3D printing help our children ?
Discover how pharmaceutical 3D printing of medications offered by MB Therapeutics can improve care for our children.
MB Therapeutics receives the French Tech Emergence Grant
The Public Investment Bank grants MB Therapeutics a subsidy for the development of next-generation drugs.
MB Therapeutics Expands its Team with the Arrival of Léna Lemierre, an Expert in Pharmaceutical 3D Printing
Discover how Léna Lemierre, an expert in pharmaceutical 3D printing, is accelerating the development of personalized medicine.